AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12443576
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy plus anisodamine
Trial: 6749701
Drug: Isoaminile citrate
RxNorm normalized name: isoaminile citrate
DrugBank: Isoaminile (DB08944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoaminile citrate (40 mg, 3 x daily)
Trial: 6749701
Drug: Chlophedianol hydrochloride
RxNorm normalized name: Chlophedianol hydrochloride
DrugBank: Clofedanol (DB04837)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlophedianol hydrochloride (20 mg, 3 x daily)
Trial: 6749701
Drug: Chlophedianol hydrochloride
RxNorm normalized name: Chlophedianol hydrochloride
DrugBank: Clofedanol (DB04837)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlophedianol hydrochloride (20 mg)
Trial: 6749701
Drug: Isoaminile citrate
RxNorm normalized name: isoaminile citrate
DrugBank: Isoaminile (DB08944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoaminile citrate (40 mg)
Trial: 25716730
Drug: MMSC infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MMSC infusion after allo-BMT
Trial: 1866755
Drug: Oral dextromethorphan
RxNorm normalized name: dextromethorphan Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dextromethorphan (60 mg q.i.d.) for 3 weeks
Trial: 23525797
Drug: Complete disruption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete disruption of TP53 function (combination of point mutations and/or del17p)
Trial: 19698011
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with losartan 50 mg and hydrochlorothiazide 12.5 mg/day
Trial: 19698011
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg/day (control group)
Trial: 14973803
Drug: Acupressure treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupressure treatment (n = 75)
Trial: 31178422
Drug: macitentan 10
RxNorm normalized name: macitentan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: macitentan 10 mg once daily
Trial: 22336903
Drug: 640 mg
RxNorm normalized name: glycerin 1640 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 640 mg anthocyanins daily
Trial: 22132138
Drug: BIS-guided propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BIS-guided propofol infusion titrated to a BIS level of 65-75
Trial: 18654005
Drug: Phase III
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase III cardiac rehabilitation program (exercise training, diet therapy, and weekly counseling for 6 months)
Trial: 17054108
Drug: FEC-HD (fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEC-HD (fluorouracil 750 mg/m(2) on Days 1 to 4, epirubicin 35 mg/m(2) on Days 2 to 4, cyclophosphamide 400 mg/m(2) on Days 2 to 4 for 4 cycles every 21 days) with lenograstim
Trial: 17054108
Drug: FEC 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEC 75 (fluorouracil 500 mg/m(2), epirubicin 75 mg/m(2), cyclophosphamide 500 mg/m(2) on Day 1 every 21 days for 4 cycles)
Trial: 8694298
Drug: Propofol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1.25 or 2.5 mg/kg
Trial: 8694298
Drug: Eltanolone 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltanolone 0.5 or 1 mg/kg
Trial: 1461627
Drug: Low-dose megestrol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose megestrol acetate (480 mg/day)
Trial: 1461627
Drug: High-dose megestrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose megestrol acetate (960 mg/day)
Trial: 6322207
Drug: Enalapril maleate
RxNorm normalized name: Enalapril Maleate
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril maleate (10 to 40 mg per day) with hydrochlorothiazide (50 mg per day) and alpha-methyldopa (250 to 1000 mg per day if necessary)
Trial: 6322207
Drug: Hydrochlorothiazide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (50 mg per day) with propranolol (80 to 240 mg per day) and hydralazine (100 to 200 mg per day if necessary)
Trial: 30855708
Drug: Active rTMS
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active rTMS treatment (10 sessions, one daily)
Trial: 30855708
Drug: Placebo rTMS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo rTMS treatment
Trial: 29463150
Drug: 3.75 mg
RxNorm normalized name: zopiclone 3.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg prasugrel
Trial: 24583820
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg i.v. dexamethasone
Trial: 15653007
Drug: Low-dose continuous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose continuous combined HRT (1 mg 17beta-estradiol plus 0.5 mg norethisterone acetate)
Trial: 15653007
Drug: Sequential combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential combined HRT (0.625 mg conjugated equine estrogens for 28 days plus 5 mg medrogestone for 14 days)
Trial: 12040969
Drug: Diclofenac effervescent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac effervescent tablet (DIC-BT) 150 mg/d for 7 days
Trial: 12040969
Drug: Diclofenac enteric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac enteric coated dragees (DIC-mrD) 150 mg/d for 7 days
Trial: 12040969
Drug: Diclofenac dispersible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac dispersible tablets (DIC-DispT) 150 mg/d for 7 days
Trial: 12040969
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 1500 mg/d for 7 days (positive control)
Trial: 9620500
Drug: Conjugated estrogen
RxNorm normalized name: Conjugated estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogen (CE) 100 mg i.v. (20 mL) at the beginning of the procedure and a second dose of CE (100 mg i.v.) just after reperfusion of the new graft.
Trial: 9620500
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 mL of isotonic sodium chloride solution) at the beginning of the procedure and a second dose of placebo (20 mL of isotonic sodium chloride solution) just after reperfusion of the new graft.
Trial: 2360542
Drug: New milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New milk product (860 mL)
Trial: 2360542
Drug: Normal milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal milk (1000 mL)
Trial: 17265458
Drug: T2000 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T2000 (400 mg)
Trial: 17265458
Drug: T2000 (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T2000 (300 mg)
Trial: 17265458
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of T2000 (800 mg daily)
Trial: 12666946
Drug: 25% metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% metronidazole dental gel applied subgingivally on days 0 and 7 as an adjunct to scaling and root planing (SRP)
Trial: 7659916
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine solution using 50% dimethylsulfoxide as a vehicle
Trial: 7659916
Drug: Similar solution
RxNorm normalized name: Antigonadotropins and similar agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Similar solution without cyclosporine
Trial: 2891032
Drug: Antacids or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacids or H2 blockers
Trial: 29510649
Drug: Clomiphene Citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene Citrate (100 mg)
Trial: 27824633
Drug: Inositol (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inositol (6 to 18 g/day)
Trial: 25749502
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) 5 μg/kg/d for 5 days and then every third day (12 total doses) + darbopoietin α 40 mcg/wk for 4 weeks (GDP group)
Trial: 25749502
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) + darbopoietin α (GDP group)
Trial: 20403998
Drug: Celecoxib treatment
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib treatment (200 mg and 400 mg)
Trial: 12456380
Drug: Intravenous montelukast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous montelukast (7 or 14 mg)
Trial: 10615075
Drug: Hepatic arterial
RxNorm normalized name: Sus scrofa artery preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatic arterial infusion of floxuridine plus systemic fluorouracil (with or without leucovorin)
Trial: 10615075
Drug: Systemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic therapy alone (monotherapy)
Trial: 1768058
Drug: Abrasio only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrasio only treatment
Trial: 1768058
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose gestagen therapy recommended for patients with CGH and high PgR concentration
Trial: 30368658
Drug: Tylerdipine 5-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tylerdipine 5-30 mg (SAD study)
Trial: 30368658
Drug: Tylerdipine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tylerdipine 10 or 20 mg (MAD study)
Trial: 28664722
Drug: Drug consumption
RxNorm normalized name: DRUGS FOR CONSTIPATION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug consumption among adolescents
Trial: 28664722
Drug: Designer drug
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Designer drug consumption
Trial: 28664722
Drug: Knowledge about
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knowledge about designer drugs
Trial: 26407095
Drug: Krill oil
RxNorm normalized name: Krill oil
DrugBank: Krill oil (DB16615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Krill oil (2 g/day)
Trial: 23371457
Drug: Jitongning Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jitongning Capsule
Trial: 15042388
Drug: EECP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EECP therapy with 5000 IU heparin pretreatment (H group)
Trial: 15042388
Drug: Conventional EECP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional EECP therapy (C group)
Trial: 15042388
Drug: EECP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EECP therapy with heparin pretreatment (H group)
Trial: 8166475
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment protocols
Trial: 2844044
Drug: Rubber band
RxNorm normalized name: CLOSURE,RUBBER BAND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rubber band ligation (RBL) + unprocessed bran (twice-daily intake for 18 months)
Trial: 29573212
Drug: General medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General medication use
Trial: 29573212
Drug: Medication use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication use by age
Trial: 28707771
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg vaginal progesterone daily from 18 to 34 weeks gestation
Trial: 28707771
Drug: Placebo ovule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ovule daily from 18 to 34 weeks gestation
Trial: 24408336
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg caffeine tablet
Trial: 21176950
Drug: 440 mg
RxNorm normalized name: placebo 440 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 440 mg albendazole and 40 mg/kg praziquantel
Trial: 21176950
Drug: 440 mg
RxNorm normalized name: placebo 440 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 440 mg albendazole
Trial: 17165280
Drug: Leukotriene modifier
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukotriene modifier drugs
Trial: 17165280
Drug: Leukotriene modifier
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukotriene modifier drugs in combination with systemic corticosteroids
Trial: 11068974
Drug: TNS +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TNS + paroxetine (20 mg)
Trial: 11068974
Drug: TNS +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TNS + paroxetine (40 mg)
Trial: 11068974
Drug: TNS +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TNS + paroxetine (20 mg) (compliant participants)
Trial: 11068974
Drug: TNS +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TNS + paroxetine (40 mg) (compliant participants)
Trial: 8616547
Drug: Once weekly
RxNorm normalized name: Actonel 35 4-Week Once Weekly Dosepack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once weekly follow-up of pulmonary rehabilitation after home rehabilitation (Group A)
Trial: 8616547
Drug: Once monthly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Once monthly follow-up of pulmonary rehabilitation after home rehabilitation (Group B)
Trial: 1424417
Drug: Ketorolac by
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac by titration
Trial: 1424417
Drug: Ketorolac by
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac by bolus injection
Trial: 3916836
Drug: liposteroid (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: liposteroid (2.5 mg of dexamethasone)
Trial: 3916836
Drug: Decadron (3.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decadron (3.3 mg of dexamethasone)
Trial: 27593706
Drug: Omeprazole (OME)
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole (OME) 20-60 mg daily
Trial: 15342613
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg etoricoxib alone and following daily doses of 400 mg ketoconazole
Trial: 15342613
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg etoricoxib alone and following daily doses of 600 mg rifampin
Trial: 15342613
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg etoricoxib once daily for 11 days
Trial: 8074755
Drug: Albendazole (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (three 400‐mg doses)
Trial: 2899357
Drug: Intranasal application
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal application of local anesthetic (bupivacaine or cocaine)
Trial: 29797800
Drug: 6-month lifestyle
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month lifestyle intervention alongside CPAP treatment
Trial: 22588361
Drug: Placebo (flour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (flour capsule)
Trial: 20634084
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of autologous platelet-rich plasma
Trial: 16652216
Drug: Hiberix (booster
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hiberix (booster dose)
Trial: 16652216
Drug: Hiberix and
RxNorm normalized name: Hiberix
DrugBank: Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen (DB10990)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hiberix and Infanrix‐DTPa (booster dose)
Trial: 10853207
Drug: Granisetron 40
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron 40 micrograms/kg plus dexamethasone 8 mg intravenously
Trial: 8339858
Drug: Ponalrestat (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ponalrestat (600 mg per day for 3 months)
Trial: 3522040
Drug: metrizamide 240
RxNorm normalized name: metrizamide
DrugBank: Metrizamide (DB01578)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: metrizamide 240 mg I/ml
Trial: 29234966
Drug: Collaborative multidisciplinary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collaborative multidisciplinary program for antibiotic prophylaxis
Trial: 24786013
Drug: Orally soluble
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally soluble film (OSF) of 50 mg sildenafil
Trial: 24786013
Drug: Film-coated tablet
RxNorm normalized name: ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Film-coated tablet (FCT) of 50 mg sildenafil
Trial: 18334811
Drug: Iscador M
RxNorm normalized name: Coenzyme M
DrugBank: Coenzyme M (DB09110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iscador M 5 mg spezial (IM spez)
Trial: 10078556
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (20 IU H-Insulin 100 Hoechst)
Trial: 10078556
Drug: Vehicle (2.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle (2.7 mg/ml m-Cresol)
Trial: 7851587
Drug: Low-dose GnRH-a
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose GnRH-a (250 micrograms SC leuprolide acetate) and hMG with elevated LH (> 35 mIU/mL)
Trial: 7851587
Drug: Low-dose GnRH-a
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose GnRH-a (250 micrograms SC leuprolide acetate) and hMG with non-elevated LH (< 35 mIU/mL)
Trial: 2184694
Drug: piritramide 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: piritramide 0.1 mg/kg
Trial: 7387140
Drug: Netilmicin 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netilmicin 1.0 mg/kg
Trial: 7387140
Drug: Gentamicin 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 1.0 mg/kg
Trial: 7387140
Drug: Netilmicin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netilmicin 2.5 mg/kg
Trial: 7387140
Drug: Gentamicin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 2.5 mg/kg
Trial: 28634972
Drug: 5-day treatment
RxNorm normalized name: 30 day Acne Treatment Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day treatment course with prednisone
Trial: 28634972
Drug: 14-day treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 14-day treatment course with prednisone
Trial: 9852387
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) - 2 mg estradiol (E2) for 12 days, followed by 2 mg E2 and 1 mg norethisterone acetate for 10 days, then 1 mg E2 for 6 days, cyclically during 6 months.
Trial: 8770316
Drug: L-arginine (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (16 g i.v.)
Trial: 2287058
Drug: BMY-28100 (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMY-28100 (750 mg daily, divided into 3 administrations for at least 14 days)
Trial: 2287058
Drug: CCL (cefaclor,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCL (cefaclor, 1,500 mg daily, divided into 3 administrations for at least 14 days)
Trial: 6169509
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia (20% benzocaine)
Trial: 26811055
Drug: Tablet-based game
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tablet-based game (3 × 10 min)
Trial: 22277140
Drug: Carvedilol controlled‐release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol controlled‐release plus lisinopril (C+L)
Trial: 22277140
Drug: Hydrochlorothiazide plus
RxNorm normalized name: hydralazine hydrochloride / hydrochlorothiazide Oral Capsule [Hydralazine Plus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide plus lisinopril (H+L)
Trial: 17559737
Drug: Posaconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posaconazole (200 mg once daily)
Trial: 17559737
Drug: Phenytoin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin (200 mg once daily)
Trial: 17559737
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of posaconazole and phenytoin (both 200 mg once daily)
Trial: 16299322
Drug: Nasal insufflation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal insufflation of MCP-CRM197 conjugate vaccine mixed with chitosan (2 doses, 28 days apart)
Trial: 16299322
Drug: Nasal insufflation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal insufflation of MCP-CRM197 conjugate vaccine mixed with chitosan (1 dose)
Trial: 16299322
Drug: Nasal insufflation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal insufflation of MCP-CRM197 conjugate vaccine mixed with chitosan